813 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel Backing http://www.zacks.com/stock/news/223352/biotech-stock-roundup-juno-in-and-out-of-clinical-hold-amgen-biosimilar-gets-panel-backing?cid=CS-ZC-FT-223352 Jul 13, 2016 - Immuno-oncology focused Juno (JUNO) remained in the news with the FDA first placing a clinical hold on a pivotal study and then removing it.
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx http://www.zacks.com/stock/news/223446/the-zacks-analyst-blog-highlights-juno-amgen-abbvie-gilead-and-cytrx?cid=CS-ZC-FT-223446 Jul 14, 2016 - The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan http://www.zacks.com/stock/news/223470/amgen-and-daiichi-sankyo-team-up-for-biosimilars-in-japan?cid=CS-ZC-FT-223470 Jul 14, 2016 - Amgen (AMGN) inked an exclusive agreement with Daiichi Sankyo for the commercialization of nine biosimilars in Japan.
Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint http://www.zacks.com/stock/news/225072/alexion-alxn-q2-earnings-stock-likely-to-disappoint?cid=CS-ZC-FT-225072 Jul 26, 2016 - Alexion Pharmaceuticals (ALXN), which is set to report second-quarter 2016 results on Jul 28, had delivered a negative earnings surprise of 4.40% last quarter.
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise? http://www.zacks.com/stock/news/224843/celgene-celg-q2-earnings-can-the-stock-pull-a-surprise?cid=CS-ZC-FT-224843 Jul 25, 2016 - Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2 http://www.zacks.com/stock/news/224851/bristol-myers-bmy-stock-to-beat-earnings-again-in-q2?cid=CS-ZC-FT-224851 Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise? http://www.zacks.com/stock/news/224914/ariad-aria-to-report-q2-earnings-will-the-stock-surprise?cid=CS-ZC-FT-224914 Jul 26, 2016 - Focus will remain on the performance of ARIAD's (ARIA) leukemia drug, Iclusig.
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen http://www.zacks.com/stock/news/224406/the-zacks-analyst-blog-highlights-zafgen-celgene-amgen-abbvie-and-biogen?cid=CS-ZC-FT-224406 Jul 21, 2016 - The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain? http://www.zacks.com/stock/news/224276/eli-lilly-lly-may-beat-q2-earnings-will-the-stock-gain?cid=CS-ZC-FT-224276 Jul 21, 2016 - The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
Stock Market News for July 21, 2016 http://www.zacks.com/stock/news/224420/stock-market-news-for-july-21-2016?cid=CS-ZC-FT-224420 Jul 21, 2016 - Sharp growth in Microsoft’s cloud computing business helped both the Dow and the S&P 500 to close at fresh record highs on Wednesday

Pages: 1234567891011...82

<<<Page 6>